Akut mieloid leukémia (AML): vizsgálatok itt: Kína
226 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleA Study of A-CAR028 Treatment in Subjects With Relapsed or Refractory Acute Myeloid Leukemia
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 20
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07198867 - 1. fázisTaking peopleA Study of BL-M11D1 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Where
- Beijing, Chengdu, Haerbin, Hefei, Jinan, Shanghai, Shenyang, Tianjin
- Életkor
- 18 év to 75 év
- People
- 130
- Run by
- Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT05924750 - 2. fázisTaking peopleMitoxantrone Hydrochloride Liposome, Standard-dose of Cytarabine and Venetoclax in the Treatment of R/R AML
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 72
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT06621212 - 2. fázisTaking peopleVenetoclax Combining Chidamide and Azacitidine (VCA) in the Treatment of R/R AML
- Where
- Xiamen
- Életkor
- 18 év and over
- People
- 30
- Run by
- The First Affiliated Hospital of Xiamen University
See details and how to joinNCT05305859 - 1. fázisTaking peopleuCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies
- Where
- Tianjin
- Életkor
- 18 év to 70 év
- People
- 12
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07109518 - Korai 1. fázisTaking peopleDonor Derived CD117 CAR-T Cells in the Treatment of R/R Acute Myeloid Leukemia
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 50
- Run by
- Zhejiang University
See details and how to joinNCT07144020 - 1. fázisTaking peopleA Study of GLB-001 in Patients With Myeloid Malignancies
- Where
- Beijing, Chongqing, Hangzhou, Hefei, Nanchang, Shanghai, Shenyang, Shijiazhuang, Suzhou, Tianjin, Wenzhou, Wuhan, Zhengzhou
- Életkor
- 18 év and over
- People
- 108
- Run by
- Hangzhou GluBio Pharmaceutical Co., Ltd.
See details and how to joinNCT06378437 - Korai 1. fázisTaking peopleThe Efficacy and Safety Assessment of Allogeneic γδ T Cells in Patients With MRD-positive AML After Allo-HSCT
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 10
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07126782 - 3. fázisTaking peopleA Study to Evaluate HMPL-306 in Patients With IDH1or IDH2-mutated Acute Myeloid Leukemia
- Where
- Baoding, Beijing, Changchun, Changsha, Chengde, Chengdu, Chongqing, Fuzhou, Guangzhou, Guanzhou, Guiyang, Hangzhou, Harbin, Hefei, Jinan, Kunming, Luoyang, Nanchang, Nanjing, Nanning, Quanzhou, Shanghai, Shenyang, Shenzhen, Shijiazhuang, Suzhou, Tianjin, Ürümqi, Wenzhou, Wuhan, Wuxi, Xiamen, Xi'an, Xuzhou, Yibin, Zhanjiang, Zhengzhou, Zunyi
- Életkor
- 18 év and over
- People
- 316
- Run by
- Hutchmed
See details and how to joinNCT06387069 - No phaseTaking peopleVenetoclax-Decitabine in Untreated Elderly/Unfit AML
- Where
- Hebei
- Életkor
- 65 év and over
- People
- 39
- Run by
- The Second Hospital of Hebei Medical University
See details and how to joinNCT07117422 - 3. fázisTaking peopleEffectiveness of Medium-Dose Cytarabine Combined With Venetoclax for Consolidation Therapy in Elderly Patients With Intermediate to High-Risk Acute Myeloid Leukemia
- Where
- Changchun
- Életkor
- 60 év to 75 év
- People
- 68
- Run by
- Yehui Tan
See details and how to joinNCT06990321 - 2. fázisTaking peopleStudy on Optimizing the Treatment of Patients With Acute Myeloid Leukemia Based on Early Peripheral Blood Minimal Residual Disease
- Where
- Changchun
- Életkor
- 18 év and over
- People
- 70
- Run by
- Yehui Tan
See details and how to joinNCT07023588 - 2. fázisTaking peopleEfficacy of Integrated Induction-Consolidation Chemotherapy and Transplantation for Adult Acute Myeloid Leukemia: Multicenter Study
- Where
- Taiyuan
- Életkor
- 14 év to 65 év
- People
- 50
- Run by
- Shanxi Bethune Hospital
See details and how to joinNCT07108530 - 1. fázisTaking peopleCD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies
- Where
- Tianjin
- Életkor
- 18 év to 70 év
- People
- 12
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07106749 - No phaseTaking peopleChidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 184
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06386302 - No phaseTaking peopleThe Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia
- Where
- Shanghai
- Életkor
- 18 év to 65 év
- People
- 50
- Run by
- Ruijin Hospital
See details and how to joinNCT06458257 - 2. fázisNot yet taking people in KínaEfficacy and Safety of VAH as a Bridging Regimen to Allo-HCT in Relapsed/Refractory AML
- Where
- Shanghai
- Életkor
- 14 év to 70 év
- People
- 44
- Run by
- Ruijin Hospital
See details and how to joinNCT07091006 - No phaseNot yet taking people in KínaEx Vivo T-Cell-Depleted Haploidentical Transplantation Bridging With Chimeric Antigen Receptor T-cell Therapy and Prophylactic Memory T Cell Infusion for Acute Leukemia
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 18
- Run by
- Ruijin Hospital
See details and how to joinNCT07087847 - 2. fázisTaking peopleVAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma
- Where
- Shanghai
- Életkor
- 18 év to 65 év
- People
- 48
- Run by
- Ruijin Hospital
See details and how to joinNCT07028086 - 1/2. fázisTaking peopleClinical Study of U32 in Patients With Acute Myeloid Leukemia
- Where
- Suzhou
- Életkor
- 2 év to 65 év
- People
- 20
- Run by
- Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
See details and how to joinNCT07036250 - 1/2. fázisTaking peopleA New Treatment of Newly Diagnosed KIT Mutation CBF-Acute Myeloid Leukemia
- Where
- Suzhou
- Életkor
- 18 év and over
- People
- 78
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT07028073 - 2. fázisTaking peopleVenetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations
- Where
- Suzhou
- Életkor
- 14 év and over
- People
- 32
- Run by
- yuejun Liu
See details and how to joinNCT07012447 - 2. fázisTaking peoplea New Treatment of Newly Diagnosed IDH1 Mutation Acute Myeloid Leukemia
- Where
- Suzhou
- Életkor
- 18 év and over
- People
- 42
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT07007949 - 1. fázisTaking peopleA Clinical Study to Evaluate the Safety and Efficacy of CLL1 and CD38 Dual-Target CAR-T Cell Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
- Where
- Tianjin
- Életkor
- 18 év to 70 év
- People
- 37
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06880354 - 1/2. fázisCsak meghívásosEfficacy and Safety of ATO Plus ATRA in Nucleophosmin-1 Mutated Acute Myeloid Leukemia
- Where
- Tianjin
- Életkor
- 14 év to 55 év
- People
- 80
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT03031249